Cargando…

Convalescent plasma for administration of passive antibodies against viral agents

Detalles Bibliográficos
Autores principales:	Di Minno, Giovanni, Mannucci, Pier Mannuccio, Ironside, James W., Perno, Carlo Federico, Gürtler, Lutz, Aledort, Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716269/ https://www.ncbi.nlm.nih.gov/pubmed/33256373 http://dx.doi.org/10.3324/haematol.2020.267427

Ejemplares similares

Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?
por: Di Minno, Giovanni, et al.
Publicado: (2017)

Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders()
por: Di Minno, Giovanni, et al.
Publicado: (2016)

Aging with Hemophilia: The Challenge of Appropriate Drug Prescription
por: Mannucci, Pier Mannuccio
Publicado: (2019)

Hemophilia therapy: the future has begun
por: Mannucci, Pier Mannuccio
Publicado: (2020)

Thrombotic thrombocytopenic purpura and other immune-mediated blood disorders following vaccination against SARS-CoV-2
por: Mannucci, Pier Mannuccio
Publicado: (2021)

Recombinant FVIII: the milestone of modern hemophilia treatment
por: Mannucci, Pier Mannuccio
Publicado: (2023)

Past, present and future of hemophilia: a narrative review
por: Franchini, Massimo, et al.
Publicado: (2012)

Health Effects of Ambient Air Pollution in Developing Countries
por: Mannucci, Pier Mannuccio, et al.
Publicado: (2017)

Acquired von Willebrand syndrome: focused for hematologists
por: Franchini, Massimo, et al.
Publicado: (2020)

The never ending success story of tranexamic acid in acquired bleeding
por: Franchini, Massimo, et al.
Publicado: (2020)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias
por: Mancuso, Maria Elisa, et al.
Publicado: (2014)

Air Pollution, Smoking, and Plasma Homocysteine
por: Baccarelli, Andrea, et al.
Publicado: (2007)

The management of hemophilia in elderly patients
por: Franchini, Massimo, et al.
Publicado: (2007)

Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium
por: Nobili, Alessandro, et al.
Publicado: (2011)

Community and hospital pharmacists in Europe: encroaching on medicine?
por: Garattini, Livio, et al.
Publicado: (2020)

Novel evidence for a greater burden of ambient air pollution on cardiovascular disease
por: Mannucci, Pier Mannuccio, et al.
Publicado: (2019)

Bleeding Disorders in Primary Fibrinolysis
por: Franchini, Massimo, et al.
Publicado: (2021)

Prophylactic management of patients with von Willebrand disease
por: Franchini, Massimo, et al.
Publicado: (2021)

How we manage cardiovascular disease in patients with hemophilia
por: Franchini, Massimo, et al.
Publicado: (2023)

Genome-Wide Association Studies in Myocardial Infarction and Coronary Artery Disease
por: Mannucci, Pier Mannuccio, et al.
Publicado: (2010)

Improving primary care in Europe beyond COVID-19: from telemedicine to organizational reforms
por: Garattini, Livio, et al.
Publicado: (2020)

Pharmaceutical patenting in the European Union: reform or riddance
por: Garattini, Livio, et al.
Publicado: (2021)

Impact of Dietary Fats on Cardiovascular Disease with a Specific Focus on Omega-3 Fatty Acids
por: Maggioni, Aldo Pietro, et al.
Publicado: (2022)

Using convalescent whole blood or plasma as passive immune therapy for the global war against Ebola
por: Lu, Shan
Publicado: (2014)

Risk factors for COVID-19 mortality: The effect of convalescent plasma administration
por: Salazar, Martín R., et al.
Publicado: (2021)

Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
por: Garraud, Olivier
Publicado: (2020)

Pain and Frailty in Hospitalized Older Adults
por: Ardoino, Ilaria, et al.
Publicado: (2020)

(A Little) Clarity on Convalescent Plasma for Covid-19
por: Katz, Louis M.
Publicado: (2021)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Covid-19 convalescent plasma and SARS-CoV-2 viral variants
por: Joob, B., et al.
Publicado: (2021)

What changed in the Italian internal medicine and geriatric wards during the lockdown
por: D'Avanzo, Barbara, et al.
Publicado: (2021)

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia
por: Boccalandro, Elena Anna, et al.
Publicado: (2023)

Sustainable nutrition and the case of vegetable oils to match present and future dietary needs
por: Mannucci, Pier Mannuccio, et al.
Publicado: (2023)

Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19
por: Biernat, Monika Maria, et al.
Publicado: (2021)

Effects on mortality of early vs late administration of convalescent plasma in the treatment of Covid-19
por: Kocayiğit, Havva, et al.
Publicado: (2021)

How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?
por: Bloch, Evan M., et al.
Publicado: (2022)

Early administration of COVID‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy
por: Belov, Artur, et al.
Publicado: (2022)

Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment
por: Bandera, Alessandra, et al.
Publicado: (2021)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j6drpc5ngcosqu0q1044l0f3a3